AVGO vs SPIB Stock Comparison
SPIB currently leads AVGO in this stock comparison, with AIQ scores of 56 vs 49. The clearest difference is risk resilience, while AVGO has the stronger quality profile.
What is the main difference between AVGO and SPIB?
SPIB leads the current stock comparison as State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, with the clearest separation coming from risk resilience and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Broadcom Inc. vs State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB leads
SPIB leads by 7 AIQ points, primarily on Risk Resilience and Momentum, having only recently taken the lead back from AVGO.
Fragile: 4 of 4 evidence groups support SPIB, the lead recently changed hands, and its current signal state is conflicted.
Broadcom Inc.
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
The Algovestiq AIQ Score currently favors SPIB over AVGO, 56 versus 49 as of Oct 22, 2026. SPIB's advantage is driven primarily by stronger risk resilience and momentum, while AVGO holds the stronger quality profile. SPIB also shows the stronger technical structure relative to its 50-day moving average. 4 of 4 covered evidence groups favor SPIB today, and the comparison is rated Fragile on stability: the lead has already changed hands inside the comparison window. SPIB lead: Reversed — AVGO led by 4 AIQ points 30 sessions ago; SPIB now leads by 7.
Compare Broadcom Inc. and State Street SPDR Portfolio Intermediate Term Corporate Bond ETF across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare AVGO and SPIB against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Risk Resilience53 vs 85SPIB +32
- Momentum27 vs 51SPIB +24
- Quality85 vs 66AVGO +19
- Value30 vs 36SPIB +6
4 of 4 evidence groups favor SPIB. SPIB’s edge is concentrated in risk resilience and momentum; AVGO keeps a meaningful quality edge.
What changed since the last close
Latest scored session 2026-10-20, compared against the prior scored session 2026-10-19.
Largest factor move: Momentum +1, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 3 active signals are unchanged.
Largest factor move: Momentum +3
No signal started or stopped since the prior session; its 5 active signals are unchanged.
SPIB's lead widened by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — AVGO and SPIB both carry a full feed there.
The central trade-off
SPIB (State Street SPDR Portfolio Intermediate Term Corporate Bond ETF): the stronger current systematic profile, led by risk resilience and momentum.
AVGO (Broadcom Inc.): the counter-case, on quality — but at materially higher volatility, 36.5% against 3.8%.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
SPIBSPIB on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
EvenGrowth figures are not covered for both names.
Value
SPIBSPIB on the peer-relative Value factor, by 6 points.
Momentum
SPIBSPIB on the Momentum factor, by 24 points.
Lower downside
SPIBSPIB on Risk Resilience, by 32 points.
Analyst upside
EvenAnalyst targets are level or not covered for both names.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | AVGO | SPIB | Note |
|---|---|---|---|
| Implied upside to target | +48.9% | — | Level |
| Target dispersion | +49.7% | — | Lower is tighter analyst agreement |
| Consensus | Buy | — | Context, not a primary driver |
| Analysts covering | 18 | — | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
4 of 4 covered evidence groups favor SPIB. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | SPIB | 49 vs 56 |
| Fundamentals | Not covered | Not covered |
| Valuation | SPIB | Value 30 vs 36 |
| Technicals | SPIB | Price vs 50-day -6.7% vs -0.9%; vs 200-day -9.1% vs -2.8% |
| Risk Resilience | SPIB | Risk Resilience 53 vs 85 |
| Analyst expectations | Not covered | Not covered |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AVGO and SPIB and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is moderate at 7 points.
- 4 of 4 covered evidence groups point the same way. (supports the conclusion holding)
- The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on SPIB.
How the comparison changed
120 daily snapshots · Jun 21 – Oct 20SPIB lead: Reversed — AVGO led by 4 AIQ points 30 sessions ago; SPIB now leads by 7.
- Today
- SPIB +7
- 49 vs 56
- 7 sessions ago
- SPIB +3
- 52 vs 55
- 30 sessions ago
- AVGO +4
- 53 vs 49
- 90 sessions ago
- AVGO +4
- 57 vs 53
The lead changed hands 3 times in this window, most recently on Sep 18 when AVGO moved ahead of SPIB.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
0 bullish / 3 bearish
Only AVGO
- MACD Bearish Crossover — bearish, momentum, short horizon
1 bullish / 3 bearish / 1 neutral, conflicted
Only SPIB
- ATR Contraction - Coiling — neutral, volatility, short horizon (0.35%)
- 52-Week Low Proximity — bearish, risk, long horizon (0.9%)
- MACD Bullish Crossover — bullish, momentum, short horizon
Both carry 2 more signals that do not separate them: Death Cross Active, Downtrend Structure Active.
SPIB leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.03%, AIQ 0 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.03%, AIQ +1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1AVGO closes the Risk Resilience gap — currently 32 points behind, the largest single contributor to SPIB's edge.
- 2AVGO's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3SPIB's conflicting signal state resolves bearish — it currently carries 1 bullish and 3 bearish rules at once.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
Split| Metric | AVGO | SPIB |
|---|---|---|
| Revenue growth (YoY) | 14.9% | — |
| EPS growth (YoY) | 26.5% | — |
| Gross margin | 67% | — |
| Operating margin | 43.7% | — |
| Return on equity (TTM) | 36.4% | — |
| Debt to equity | 0.74 | — |
Performance
SPIB leads 5 of 6 windows| Metric | AVGO | SPIB |
|---|---|---|
| 1 week (5 sessions) | -6.4% | 0.2% |
| 1 month (20 sessions) | -8.3% | -0.9% |
| 3 months (63 sessions) | -15.7% | -2.2% |
| 6 months (126 sessions) | -16.4% | -3.7% |
| Year to date | -3.4% | -4.2% |
| 1 year (252 sessions) | -5.6% | -4.8% |
Technicals
SPIB has the stronger structure| Metric | AVGO | SPIB |
|---|---|---|
| RSI (14) | 41.8 | 60.7 |
| ADX (14) | 21.4 | 28.1 |
| Price vs 50-day | -6.7% | -0.9% |
| Price vs 200-day | -9.1% | -2.8% |
| Volatility (1M, annualized) | 36.5% | 3.8% |
Risk
SPIB is the more resilient| Metric | AVGO | SPIB |
|---|---|---|
| Beta | 2.16 | 0.11 |
| Sharpe ratio | 0.05 | -2.63 |
| Sortino ratio | 0.07 | -3.48 |
| Max drawdown | -31.7% | -5.7% |
| Current drawdown | -30.6% | -5% |
| Annualized volatility | 45.9% | 3.3% |
| Value at risk (95%) | -4.4% | -0.4% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, AVGO or SPIB?
On the Algovestiq AIQ Score, SPIB is the stronger of the two as of Oct 22, 2026, scoring 56 against AVGO's 49. The edge comes from risk resilience and momentum. AVGO is not without a case — it holds the better quality profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is AVGO or SPIB the better buy right now?
SPIB carries the stronger systematic profile as of Oct 22, 2026, and the comparison is rated Fragile — 4 of 4 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the lead has already changed hands inside the comparison window. Treat the lead as provisional.
Why does the AIQ Score favor SPIB over AVGO?
The composite weights Quality, Value, Momentum and Risk Resilience. SPIB leads Risk Resilience by 32 points; SPIB leads Momentum by 24 points; AVGO leads Quality by 19 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, AVGO or SPIB?
Analyst price targets imply +48.9% upside for AVGO and not covered for SPIB. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, AVGO or SPIB?
SPIB is the better-valued of the two on the peer-relative Value factor. SPIB on the peer-relative Value factor, by 6 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, AVGO or SPIB?
Growth figures are not covered for both names. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, AVGO or SPIB?
SPIB on the Momentum factor, by 24 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, AVGO or SPIB?
SPIB is the more resilient of the two, so the other name carries the higher downside risk. SPIB on Risk Resilience, by 32 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is AVGO more profitable than SPIB?
Margin data is not comparable for both names in the current snapshot.
Is SPIB's lead over AVGO getting stronger or weaker?
SPIB lead: Reversed — AVGO led by 4 AIQ points 30 sessions ago; SPIB now leads by 7. This is measured from 120 daily comparison snapshots between 2026-06-21 and 2026-10-20. The lead has changed hands 3 times in that window, most recently on 2026-09-18, when AVGO moved ahead of SPIB.
What would change the AVGO vs SPIB verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: AVGO closes the Risk Resilience gap — currently 32 points behind, the largest single contributor to SPIB's edge; AVGO's Death Cross Active resolves — a bearish trend rule currently active against it; SPIB's conflicting signal state resolves bearish — it currently carries 1 bullish and 3 bearish rules at once; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about AVGO and SPIB?
AVGO: 0 bullish / 3 bearish. SPIB: 1 bullish / 3 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AVGO is Death Cross Active (bearish, long horizon). On SPIB it is Death Cross Active (bearish, long horizon).
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.